An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor

clinical trial

Details

Instance of: clinical trial
Start time: October 2015
End time: March 2017
Country: United States
Main subject: essential tremor, tremor
clinical trial phase: phase II clinical trial
minimum age: 18
number of participants: 16
study type: interventional study
title: A Double-Blind, Cross-Over, Placebo-Controlled Efficacy and Tolerability Study of Perampanel and Essential Tremor

Nothing in the MetaHistoryBook collection references this item yet.